Navigation Links
Micromet, Inc. Reports First Quarter 2009 Financial Results
Date:5/6/2009

or development expenses incurred in this collaboration.

  • On January 13, Micromet together with the Ludwig-Maximilian-University in Munich, Germany published data in the peer reviewed journal Nature Cell Biology revealing a novel signaling function of the epithelial cell adhesion molecule, or EpCAM, which is expressed at high frequency on many tumor types. The data indicate that only cancer cells have an active signaling form of EpCAM that promotes tumor formation. This data further supports the scientific and clinical rationale behind two of Micromet's most advanced clinical product candidates, adecatumumab and MT110, both of which target EpCAM.

  • On February 23, Micromet announced the addition of Kapil Dhingra, M.D. to the Board of Directors. Dr. Dhingra has been active in oncology clinical research for over 20 years, most recently as head of Oncology Development at Hoffman La-Roche, where he built the largest oncology clinical development department in the industry. Dr. Dhingra brings deep oncology development experience and perspective to Micromet's Board of Directors.

  • On March 12, Micromet announced that it had regained North American rights to its most advanced product candidate, blinatumomab (MT103), from MedImmune. Micromet is responsible for the further clinical development and commercialization of blinatumomab. MedImmune is obligated to complete the development of the commercial scale manufacturing process for blinatumomab at its cost. Upon the first marketing approval of blinatumomab in the United States, MedImmune will have a one-time option to reacquire the commercialization rights in North America at pre-defined terms.

  • On March 23, Micromet announced the initiation of a new pha
    '/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Micromet, Inc. Reports First Quarter 2008 Financial Results
2. Micromet, Inc. Reports Second Quarter 2008 Financial Results
3. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... (HealthDay News) -- The West African Ebola outbreak took a ... an estimated 500 new cases this week -- the biggest ... cases arose in Liberia, the U.N. health agency said, but ... Associated Press reported. "There are serious problems ... the WHO report. "The situation is worsening in Liberia and ...
(Date:8/29/2014)... September yoga month was created by the Yoga Health ... benefits. To support this Ekhart Yoga is offering those ... , This 4 week guided online yoga program is ... yoga regularly from their own home. Led by Esther ... for all levels, and the dynamic classes will help ...
(Date:8/29/2014)... RBS Reputation Management has brought a new ... service is to help those individuals and organizations that are ... Book. The service would push down the ranking of Scam ... fully invisible on Google. , RBS Reputation Management provides ... asked how company can provide guarantee of results with the ...
(Date:8/29/2014)... Last week, the Fed reported an increase ... production rose to 0.4% while manufacturing output progressed to 1.0%. ... largest boost since February this year. Capacity use has increased ... well – an increase that could be attributed to the ... rate, which is a measure of slack across the industries. ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Ethane Web ... recently launched a new service named HTML web design. ... based service. Before tailoring the service, Ethane Web Technologies ... other companies. The company has done its best efforts ... and able to deliver outstanding results to clients. ...
Breaking Medicine News(10 mins):Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 2Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 3Health News:Ekhart Yoga Launches the Yoga Month Challenge 2Health News:RBS Reputation Management Announces a New Online Reputation Management Service 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3Health News:Ethane Web Technologies Launches a New Web Design Service 2
... that the usage of aspirin to prevent heart problem have ... of Pittsburgh Graduate School of Public Health (GSPH) and others ... Medicine. It said that African Americans and diabetics do not ... medical centers of US and Europe measured regular use of ...
... conducted by Jerald Greenberg professor of management and human resources ... that pay cuts resulted in loss of money and sleep ... in different cities in the Northeast. ,In these ... salary by 10%. The author conducted a supervisor training in ...
... Derek Griffiths, Ph.D., professor of geriatric medicine, University of Pittsburgh ... to the reduced activity of the orbitofrontal cortex of the ... recent issue of the Journal of Urology. He studied the ... , He analyzed the brain activity of 6 normal people ...
... was stated that Malaria affects 300 to 500 million people ... leading// cause of illness and death in the sub-Saharan African ... the Uganda Malaria Surveillance Project and Julia Critchley of the ... drugs showed better efficiency when used in the treatment of ...
... the number of breast cancer cases in the UK. As ... with the ductal carcinoma// in situ (DCIS) during 2002. The ... the hormone therapy drugs are capable of preventing the recurrence ... anastrozole are being studied. The DCIS is considered a pre-cancerous ...
... with regard to a ten-year-old plan to scale down the ... and the rich with regard to this however remains unchanged. ... the establishment of 34 networks for providing better treatment. As ... ,Improvements have been made with regard to ...
Cached Medicine News:Health News:Pay Cut Leads To Increased Levels Of Insomnia Among Workers 2Health News:Older Malarial Drugs Vs New Ones 2
(Date:8/29/2014)... 2014 Research and Markets  has announced the ... 2014" report to their offering. The ... of the largest segments of pharmaceuticals industry. The numbers of ... available therapies were unable to meet the market requirements. There ... CNS disorder, especially over the past two decades. The market ...
(Date:8/29/2014)... , Aug. 29, 2014   Vittamed Corporation , a ... announced today that T. (Teo) Forcht Dagi , ... company,s Board of Directors. " Teo Forcht ... in neurosurgery, medical innovation and venture capital," said Remis ... delighted to add his clinical, strategic, and entrepreneurial expertise to ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Multiple Sclerosis Drugs Market 2014-2018" report to ... chronic, inflammatory medical condition that results in demyelination, axonal ... of an abnormal response by the immune system, which ... is a potentially debilitating disease in which the damage ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... stimulants combined provide greater improvement in symptoms ... Addrenex Pharmaceuticals, Inc. today announced positive results ... Clonicel demonstrating that the combination of Clonicel ... in attention deficit hyperactivity disorder (ADHD) symptoms ...
... After a review of several vendors, the University ... selected the services of Velos and its flagship product, ... implemented at UCLA,s Jonsson Comprehensive Cancer Center and an ... Plans are in place to deploy the system in ...
Cached Medicine Technology:Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication 2University of California Los Angeles Selects Velos eResearch 2University of California Los Angeles Selects Velos eResearch 3University of California Los Angeles Selects Velos eResearch 4University of California Los Angeles Selects Velos eResearch 5University of California Los Angeles Selects Velos eResearch 6
... be used only with the E3671 twisted snare ... the wing nut and the loop can be ... ratchet so that the loop can be slipped ... length - 5.6 inches. Comes with one package ...
Open 14 mm fixation ring with teeth to prevent damage to conjuctiva. Gauge is marked every 10 degrees to determine the extent of the arc to be incised. Two broad marks align with steep axis....
... Titanium. Designed to fixate the ... The two-sided ring can easily ... pointed or smooth side on ... pressure to the eye to ...
For sterilizing, carrying and storage of a Storz diamond knife and barrel gauge....
Medicine Products: